StockNews.com Downgrades HCA Healthcare (NYSE:HCA) to Buy

HCA Healthcare (NYSE:HCAGet Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued on Sunday.

A number of other brokerages also recently commented on HCA. Baird R W upgraded shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Robert W. Baird began coverage on shares of HCA Healthcare in a report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 target price for the company. Deutsche Bank Aktiengesellschaft increased their target price on shares of HCA Healthcare from $330.00 to $359.00 and gave the company a “buy” rating in a report on Friday, April 12th. Wells Fargo & Company increased their target price on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a report on Thursday, March 28th. Finally, TD Cowen dropped their target price on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a report on Tuesday, April 30th. Four analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $325.59.

Read Our Latest Stock Report on HCA

HCA Healthcare Price Performance

Shares of HCA opened at $335.47 on Friday. HCA Healthcare has a fifty-two week low of $215.96 and a fifty-two week high of $343.53. The company has a market capitalization of $87.86 billion, a price-to-earnings ratio of 16.72, a price-to-earnings-growth ratio of 1.56 and a beta of 1.69. The firm has a 50-day simple moving average of $320.93 and a 200-day simple moving average of $313.36. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, topping the consensus estimate of $5.01 by $0.35. The business had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $16.81 billion. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The business’s quarterly revenue was up 11.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $4.93 earnings per share. On average, equities research analysts anticipate that HCA Healthcare will post 20.92 earnings per share for the current year.

Insider Buying and Selling

In related news, SVP Chad J. Wasserman sold 876 shares of the company’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $330.25, for a total transaction of $289,299.00. Following the completion of the sale, the senior vice president now directly owns 1,576 shares of the company’s stock, valued at approximately $520,474. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other HCA Healthcare news, SVP Chad J. Wasserman sold 876 shares of the company’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $330.25, for a total value of $289,299.00. Following the completion of the transaction, the senior vice president now directly owns 1,576 shares of the company’s stock, valued at approximately $520,474. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total transaction of $303,576.00. Following the completion of the transaction, the senior vice president now directly owns 22,365 shares of the company’s stock, valued at $6,977,880. The disclosure for this sale can be found here. In the last three months, insiders sold 13,273 shares of company stock valued at $4,211,228. Company insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On HCA Healthcare

Institutional investors have recently modified their holdings of the stock. Norges Bank acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $694,985,000. Royal Bank of Canada boosted its holdings in shares of HCA Healthcare by 35.7% in the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after acquiring an additional 1,183,890 shares in the last quarter. Capital World Investors boosted its holdings in shares of HCA Healthcare by 57.5% in the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after acquiring an additional 1,019,750 shares in the last quarter. Sanders Capital LLC boosted its holdings in shares of HCA Healthcare by 4.2% in the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after acquiring an additional 456,738 shares in the last quarter. Finally, TD Asset Management Inc boosted its holdings in shares of HCA Healthcare by 230.5% in the fourth quarter. TD Asset Management Inc now owns 553,225 shares of the company’s stock valued at $149,747,000 after acquiring an additional 385,854 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

About HCA Healthcare

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.